Evidence map›Paper›PMID 35250298›Full record

ArticleInternational journal of general medicine2022

Predictors of Mortality for Patients with COVID-19 in the Rural Appalachian Region.

Huzefa Bhopalwala, Nakeya Dewaswala, Sandhya Kolagatla, Lauren Wisnieski, Jonathan Piercy, Adnan Bhopalwala, Nagabhishek Moka

Abstract read
In one paragraph

Article in International journal of general medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Pathophysiology and Management of Heart Failure in the Elderly.The International journal of angiology : official publication of the International College of Angiology, Inc · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Huzefa BhopalwalaDepartment of Internal Medicine, Appalachian Regional Healthcare, Whitesburg, KY, USA.ORCID 0000-0002-4289-7288
Nakeya DewaswalaDepartment of Cardiovascular Disease, University of Kentucky, Lexington, KY, USA.
Sandhya KolagatlaDepartment of Internal Medicine, Appalachian Regional Healthcare, Whitesburg, KY, USA.
Lauren WisnieskiDepartment of Public Health and Research, Lincoln Memorial University, Harrogate, TN, USA.
Jonathan PiercyDepartment of Internal Medicine, Appalachian Regional Healthcare, Whitesburg, KY, USA.
Adnan BhopalwalaDepartment of Internal Medicine, Appalachian Regional Healthcare, Whitesburg, KY, USA.
Nagabhishek MokaDepartment of Internal Medicine, Appalachian Regional Healthcare, Whitesburg, KY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence and outcome of coronavirus disease 2019 (COVID-19) in rural areas is unknown.

methodsThis is a multi-center retrospective cohort study of hospitalized patients diagnosed with COVID-19 from April 5, 2020 to December 31, 2020. The data were extracted from 13 facilities in the Appalachian Regional Healthcare system that share the same electronic health record using ICD-10-CM codes.

resultsThe number of patients diagnosed with COVID-19 per facility ranged from 5 to 535 with a median of 106 patients. Total mortality was 11.4% and ranged from 0% to 22.6% by facility (median: 9.0%). Non-survivors had a greater prevalence of congestive heart failure (CHF), hypertension, type 2 diabetes mellitus, stroke, transient ischemic attack (TIA), and pulmonary embolism. Patients who died were also more likely to have had chronic obstructive pulmonary disease (COPD), acute respiratory failure (ARF), liver cirrhosis, chronic kidney disease (CKD), dementia, cancer, anemia, and opiate dependence.

conclusionThe aging population, multiple co-morbidities, and health-related behaviors make rural patients vulnerable to COVID-19. A better understanding of the disease in rural areas is crucial, given its heightened vulnerability to adverse outcomes.

Indexed as

cohortcoronavirusCOVID-19mortalitySARS-CoV-2survival

Identifiers

PMID35250298
PMCPMC8893147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.